Point: Should thoracoscopic talc pleurodesis be the first choice management for malignant effusion? Yes

Pyng Lee¹

Affiliations

¹ Division of Respiratory and Critical Care Medicine, National University Hospital, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Electronic address: pyng_lee@nuhs.edu.sg.

Editorial

Pyng Lee. Chest. 2012 Jul.

. 2012 Jul;142(1):15-17.

doi: 10.1378/chest.12-1085.

Pyng Lee¹

¹ Division of Respiratory and Critical Care Medicine, National University Hospital, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Electronic address: pyng_lee@nuhs.edu.sg.

No abstract available

Comment in

Counterpoint: should thoracoscopic talc pleurodesis be the first choice management for malignant pleural effusion? No.
Light RW. Light RW. Chest. 2012 Jul;142(1):17-19. doi: 10.1378/chest.12-1087. Chest. 2012. PMID: 22796835 No abstract available.
Management of recurrent malignant pleural effusions: an ever-recurring issue?
Maldonado F, Astoul P. Maldonado F, et al. Chest. 2012 Dec;142(6):1696. doi: 10.1378/chest.12-2038. Chest. 2012. PMID: 23208361 No abstract available.